science and technology 科技
2020年2月7日 星期五
Launching a new chapter in cancer immunotherapy field, scientists have blended two cutting-edge approaches: CRISPR and T cell therapy.
Science
Launching a new chapter in the fast-moving cancer immunotherapy field, scientists have blended two cutting-edge approaches: CRISPR and T cell therapy.
The gravely ill patients received altered versions of their own immune cells in an early test
SCIENCEMAG.ORG
Cutting-edge CRISPR gene editing appears safe in three cancer patients
The gravely ill patients received altered versions of their own immune cells in an early test
沒有留言:
張貼留言
較新的文章
較舊的文章
首頁
訂閱：
張貼留言 (Atom)
沒有留言:
張貼留言